Burger Lab

Dylan Burger profile picture

Contact Information

Dylan Burger, PhD
613-562-5800 x 8241
dburger@uottawa.ca

2513-451 Smyth Rd.
Ottawa, ON
K1H 7N9



ORCID logo https://orcid.org/0000-0003-3951-2911

Dylan Burger

Senior Scientist, Inflammation & Chronic Disease
Ottawa Hospital Research Institute
Associate Professor, Department of Cellular and Molecular Medicine
University of Ottawa
Associate Professor, School of Pharmaceutical Sciences
University of Ottawa

Research Interests

  • Extracellular vesicles
  • Diabetes
  • Hypertension
  • Kidney Disease
  • Pharmacology
  • Vascular Biology
  • Biomarkers

Brief Biography

Dylan Burger (PhD, ISHF) is a Senior Scientist at the Ottawa Hospital Research Institute and Associate Professor at the University of Ottawa (Department of Cellular and Molecular Medicine). He holds a PhD in Physiology and Pharmacology from the University of Western Ontario and completed postdoctoral studies with Drs. Rhian Touyz and Kevin Burns at the Ottawa Hospital Research Institute. His independent research program focuses on understanding the molecular underpinnings of diabetes and hypertension and their associated renal complications. In particularly he has been active in the study of extracellular vesicles as markers and mediators of vascular and renal injury for more than 10 years. He has authored more than 100 manuscripts and has received several awards including the 2016 Canadian Society of Nephrology New Investigator Lectureship and the 2018 University of Ottawa Department of Medicine PhD Scientist Award. Dr. Burger was also the recipient of a 2014 New Investigator Award from the KRESCENT program (kidney research scientist core education and national training program) which is a joint initiative through the Kidney Foundation of Canada, Canadian Society of Nephrology and the Canadian Institute of Health Research.
He is the current Chair of Publications for the Canadian Society of Extracellular Vesicles. Dr. Burger is a founding member of The Lancet Commission on Hypertension and Associate Editor for the European Heart Journal and the Journal of Extracellular Vesicles. He was co-chair of the first Molecules and Mechanisms Mediating Kidney Health and Disease Symposium in 2021.

Selected Publications

1. Munkonda MN, Akbari S, Landry C, Turner M, Sun S, Holterman CE, Nasrallah R, Hébert RL, Kennedy CRJ, Burger, D* (2018) “Podocyte-derived Microparticles Promotes Proximal Tubule Fibrotic Signaling Via p38 MAPK and CD36”. J Extracell Ves Feb 2;7(1):1432206.

2. Abolbaghaei A, Langlois MA, Murphy H, Feig D*, Burger D* (2021) “Circulating extracellular vesicles during pregnancy in women with type 1 diabetes”. Biomark Res 9(1):67.

3. Myette RL, Xiao F, Geier P, Feber J, Kennedy CRJ, Burger D (2023) “Urinary Podocyte-derived Large Extracellular Vesicles are Increased in Pediatric Idiopathic Nephrotic Syndrome”. Nephrol Dial Transpl doi: 10.1093/ndt/gfad086

4. Kereliuk SM, Xiao F, Dolinsky VW*, Burger D* (2022) “Extracellular vesicles as an index for endothelial injury and cardiac dysfunction in a rodent model of GDM”. Int J Mol Sci 23(9):4970.

5. Burger D, Thibodeau JF, Holterman CE, Burns KD, Touyz RM, Kennedy CRJ (2014) “Urinary podocyte microparticles identify pre-albuminuric diabetic glomerular injury”. J Am Soc Nephrol 25(7) 1401-1407

6. Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, Damasceno A, Delles C, Giminez-Roqueplo A, Hering D, López-Jaramillo P, Martinez F, Perkovic V, Rietzschel ER, Schillaci G, Schutte AE, Scuteri A, Sharman JE, Wachtell K, Wang JG (2016) “A call to action and a life-course strategy to address the global burden of raised blood pressure on current and future generations: The Lancet Commission on Hypertension”. Lancet 26;388(10060):2665-2712.

Diseases, conditions and populations of interest





Research and clinical approaches